Literature DB >> 11091503

Simultaneous Assay of ErbB-2 Protein and Carcinoembryonic Antigen in Cyst Fluid as an Aid in Diagnosing Cystic Lesions of the Breast.

.   

Abstract

C-erbB-2 oncoprotein (ErbB-2 protein)and carcinoembryonic antigen (CEA)were simultaneously evaluated in the breast cyst fluid of 6 patients with intracystic cancer, 6 patients with intracystic papilloma, and 42 patients with gross cystic disease. A combination test, using 12 ng of ErbB-2 protein and 150 ng of CEA/ml of cyst fluid, respectively, as cutoff values resulted in a positive detection rate of 83%(5/6 cases) for intracystic breast cancer. Two of the 6 patients with intracystic papilloma and 2 of the 42 patients with gross cystic disease were positive. In addition, elevated levels of these markers in cyst fluid correlated well with the expression of these antigens in the corresponding tumor. Thus, it can be concluded that measurements of ErbB-2 protein and CEA aid in the diagnosis of intracystic breast cancer, and the assay of ErbB-2 protein is valuable for detecting tumors in which this protein is overexpressed.

Entities:  

Year:  1994        PMID: 11091503     DOI: 10.1007/BF02967371

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  17 in total

1.  The differential diagnosis of papillary tumors of the breast.

Authors:  F T KRAUS; R D NEUBECKER
Journal:  Cancer       Date:  1962 May-Jun       Impact factor: 6.860

2.  Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.

Authors:  D M Barnes; J S Meyer; J G Gonzalez; W J Gullick; R R Millis
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Mammographic features of intracystic papillary lesions.

Authors:  A Estabrook; T Asch; F Gump; S J Kister; P Geller
Journal:  Surg Gynecol Obstet       Date:  1990-02

5.  The clinical recognition of cystic carcinoma of the breast.

Authors:  J E Devitt; J R Barr
Journal:  Surg Gynecol Obstet       Date:  1984-08

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  C-erbB-2 protein in the sera of breast cancer patients.

Authors:  T Narita; H Funahashi; Y Satoh; H Takagi
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.

Authors:  J E Somerville; L A Clarke; J D Biggart
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

9.  ErbB-2 protein levels in nipple discharge: role in diagnosis of early breast cancer.

Authors:  H Inaji; H Koyama; K Motomura; S Noguchi; Y Mori; Y Kimura; K Sugano; H Ohkura
Journal:  Tumour Biol       Date:  1993

10.  A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product.

Authors:  T Masuko; K Sugahara; M Kozono; S Otsuki; T Akiyama; T Yamamoto; K Toyoshima; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1989-01
View more
  1 in total

1.  A case of giant complicated intraductal papilloma of breast on MRI and literature review.

Authors:  Siqi Wang; Jianjuan Lou
Journal:  Cancer Rep (Hoboken)       Date:  2018-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.